GlaxoSmithKline Infringes Antibody Patent: Genentech
Genentech Inc. has fired back in a suit brought by GlaxoSmithKline PLC seeking to invalidate one of the biotechnology company's antibody patents, insisting that the drugmaker has committed infringement through the...To view the full article, register now.
Already a subscriber? Click here to view full article